News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
216 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21720)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Deals
Ambu Scoops Up Invendo Medical in EUR 225M Deal
Danish company Ambu plopped down $265M to acquire Germany-based Invendo Medical, a privately-held medtech company that develops single-use high definition endoscopy products.
October 25, 2017
·
2 min read
·
Alex Keown
Business
Why Even Spinraza Can’t Save Biogen’s Incoming MS Meltdown
Biogen released its third-quarter financials yesterday, showing total revenues of $3.1B for the quarter, a 4 percent gain compared to the same period the previous year.
October 25, 2017
·
4 min read
·
Mark Terry
BioMidwest
3 Biotechs Investors Should Put on Their Watchlist
Three companies remain favorites, and all are rated Buy at Jefferies.
October 25, 2017
·
1 min read
Biotech Bay
Sunesis Announces Pricing of $20M Offering of Securities
These offerings are expected to close on or about October 27, 2017, subject to customary closing conditions.
October 25, 2017
·
4 min read
Business
Natus Medical Announces Third Quarter 2017 Financial Results
The company reported record third quarter 2017 revenue of $122.6 million
October 25, 2017
·
16 min read
Pharm Country
Creative BioMart Launched Protein Phosphorylation Site Identification and Mapping Service
Creative BioMart announced the release of Protein Phosphorylation Site Identification and Mapping Service to serve a broader range of scientists.
October 25, 2017
·
1 min read
Business
1ST Bio and Neuraly Collaborate to Advance Novel c-Abl Inhibitors for Parkinson’s Disease
1ST Bio today announced a collaboration to co-develop novel brain penetrant c-Abl inhibitors for Parkinson’s disease.
October 25, 2017
·
3 min read
BioForest
Allen Institute Shares First Open Database Of Live Human Brain Cells
The Allen Institute for Brain Science has added the first data from human nerve cells to the Allen Cell Types Database.
October 25, 2017
·
6 min read
Genetown
Cheetah Medical Release: New Study Demonstrates the Need for Guided Intraoperative Fluids to Improve Patient Outcomes
Cheetah Medical, a Massachusetts based leader in non-invasive hemodynamic monitoring, announced new research results presented today at the American Society of Anesthesiologists Annual Meeting in Boston.
October 25, 2017
·
3 min read
Biotech Beach
Intrepid Acts As Exclusive Financial Advisor to Ambry Genetics on Its Sale to Konica Minolta in a Deal Valued at US$1 Billion
Intrepid Investment Bankers announced that it acted as the exclusive financial advisor to U.S.-based Ambry Genetics Corporation (Ambry) on its sale to Konica Minolta.
October 25, 2017
·
5 min read
Previous
2 of 22
Next